Quick Answer
Co-Diagnostics, Inc. reported Research And Development Expense of $19.14 million for the year ending 2025.
- Co-Diagnostics, Inc. showed a decrease of -8.8% in Research And Development Expense from 2024 to 2025.
- This data is from Co-Diagnostics, Inc.'s annual report (Form 10-K), filed with the SEC on March 31, 2026.
- XBRL data for this metric is available from 2016 to 2025 (10 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 10 years of available data (2016 to 2025), Co-Diagnostics, Inc.'s Research And Development Expense has grown by 2,516.3%.
- Historical annual values: Fiscal year 2025: $19.14 million | Fiscal year 2024: $20.98 million | Fiscal year 2023: $22.96 million | Fiscal year 2022: $17.44 million | Fiscal year 2021: $14.96 million | Fiscal year 2020: $3.19 million | Fiscal year 2019: $1.37 million | Fiscal year 2018: $1.36 million | Fiscal year 2017: $1.00 million | Fiscal year 2016: $731.5 thousand.
- Data sourced from SEC EDGAR public filings as of June 20, 2026.
Last verified: